GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Oncodesign Precision Medicine SA (XPAR:ALOPM) » Definitions » Price-to-Free-Cash-Flow

Oncodesign Precision Medicine (XPAR:ALOPM) Price-to-Free-Cash-Flow : (As of Apr. 26, 2024)


View and export this data going back to 2022. Start your Free Trial

What is Oncodesign Precision Medicine Price-to-Free-Cash-Flow?

As of today (2024-04-26), Oncodesign Precision Medicine's share price is €1.505. Oncodesign Precision Medicine does not have enough years/quarters to calculate the Free Cash Flow per Share for the trailing twelve months (TTM) ended in Jun. 2022. Therefore GuruFocus does not calculate Price-to-Free-Cash-Flow Ratio at this moment.

The historical rank and industry rank for Oncodesign Precision Medicine's Price-to-Free-Cash-Flow or its related term are showing as below:

XPAR:ALOPM's Price-to-Free-Cash-Flow is not ranked *
in the Biotechnology industry.
Industry Median: 30.76
* Ranked among companies with meaningful Price-to-Free-Cash-Flow only.

Oncodesign Precision Medicine's Free Cash Flow per Share for the six months ended in Jun. 2022 was €0.00.


Oncodesign Precision Medicine Price-to-Free-Cash-Flow Historical Data

The historical data trend for Oncodesign Precision Medicine's Price-to-Free-Cash-Flow can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Oncodesign Precision Medicine Price-to-Free-Cash-Flow Chart

Oncodesign Precision Medicine Annual Data
Trend Dec20 Dec21
Price-to-Free-Cash-Flow
- -

Oncodesign Precision Medicine Semi-Annual Data
Dec20 Dec21 Jun22
Price-to-Free-Cash-Flow - - -

Competitive Comparison of Oncodesign Precision Medicine's Price-to-Free-Cash-Flow

For the Biotechnology subindustry, Oncodesign Precision Medicine's Price-to-Free-Cash-Flow, along with its competitors' market caps and Price-to-Free-Cash-Flow data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Oncodesign Precision Medicine's Price-to-Free-Cash-Flow Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Oncodesign Precision Medicine's Price-to-Free-Cash-Flow distribution charts can be found below:

* The bar in red indicates where Oncodesign Precision Medicine's Price-to-Free-Cash-Flow falls into.



Oncodesign Precision Medicine Price-to-Free-Cash-Flow Calculation

Oncodesign Precision Medicine's Price-to-Free-Cash-Flow ratio for today is calculated as

Price-to-Free-Cash-Flow Ratio=Share Price/ Free Cash Flow per Share (TTM)
=1.505/
=

It can also be calculated from the numbers for the whole company:

Price-to-Free-Cash-Flow Ratio=Market Cap/Free Cash Flow

Oncodesign Precision Medicine  (XPAR:ALOPM) Price-to-Free-Cash-Flow Explanation

Free Cash Flow is considered more important than earnings by value investors. The reason is because, in principle, only the net cash that can be taken from the business belongs to shareholders. This Free Cash Flow can be used to grow the business, reduce debt or return to shareholders in dividends or share buybacks.

In a DCF Calculation Free Cash Flow is used to determine the intrinsic value of companies.


Be Aware

In real business, Free Cash Flow can be affected by the change in accounts receivable, accounts payable, management's decision on expansion, etc. Therefore, investors should look at the Free Cash Flow over the longer term. Long-term average of Free Cash Flow is a more reliable indicator for real free cash flow.


Oncodesign Precision Medicine Price-to-Free-Cash-Flow Related Terms

Thank you for viewing the detailed overview of Oncodesign Precision Medicine's Price-to-Free-Cash-Flow provided by GuruFocus.com. Please click on the following links to see related term pages.


Oncodesign Precision Medicine (XPAR:ALOPM) Business Description

Comparable Companies
Traded in Other Exchanges
N/A
Address
18 rue Jean Mazen, Dijon, FRA, 21000
Oncodesign Precision Medicine SA is a biopharmaceutical company specialised in precision medicine. Its mission is to provide patients with effective diagnostic and therapeutic solutions for resistant and metastatic cancers.

Oncodesign Precision Medicine (XPAR:ALOPM) Headlines

No Headlines